STOCK TITAN
  1. Home
  2. Sec-filings
  3. MD
  4. [Form 4] Pediatrix Medical Group, Inc. Insider Trading Activity

Director Shirley Weis receives 7,196 Pediatrix (MD) restricted shares award

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Weis Shirley A reported acquisition or exercise transactions in this Form 4 filing.

Pediatrix Medical Group director Shirley A. Weis received 7,196 restricted shares of common stock as an equity grant. The award was made at a price of $0.00 per share under the company’s Amended and Restated 2008 Incentive Compensation Plan in connection with her annual equity award.

These restricted shares are scheduled to vest on May 7, 2027. Following the grant, Weis directly holds 18,623 common shares and is also reported as an indirect owner of 36,028 common shares held by The Weis Family Trust, for which she and her husband serve as trustees and her immediate family members are beneficiaries.

Positive

  • None.

Negative

  • None.
Insider Weis Shirley A
Role null
Type Security Shares Price Value
Grant/Award Common Stock 7,196 $0.00 --
holding Common Stock -- -- --
Holdings After Transaction: Common Stock — 18,623 shares (Direct, null); Common Stock — 36,028 shares (Indirect, By The Weis Family Trust U/A dtd 04/19/2002, John N.Weis & ShirleyA. Weis Trustees)
Footnotes (1)
  1. Restricted shares granted pursuant to Issuer's Amended and Restated 2008 Incentive Compensation Plan, in connection with annual equity award. Shares will vest on May 7, 2027. The Reporting Person and her husband are trustees of the trust that holds the reported securities. Members of the Reporting Person's immediate family are beneficiaries of the trust.
Restricted shares granted 7,196 shares Equity award on May 7, 2026
Grant price per share $0.00 per share Restricted stock award
Direct holdings after grant 18,623 shares Common stock directly owned after award
Indirect trust holdings 36,028 shares Held by The Weis Family Trust
Vesting date May 7, 2027 Restricted shares vesting schedule
Restricted shares financial
"Restricted shares granted pursuant to Issuer's Amended and Restated 2008 Incentive Compensation Plan"
Restricted shares are company stock that cannot be sold or transferred immediately because they are subject to legal or contractual limits, such as a required holding period or performance conditions. They matter to investors because these locked-up shares can affect a company’s available stock for trading, future dilution, and insider incentives—imagine a gift that can’t be cashed until certain conditions are met, which changes when and how much supply can suddenly enter the market.
Amended and Restated 2008 Incentive Compensation Plan financial
"Restricted shares granted pursuant to Issuer's Amended and Restated 2008 Incentive Compensation Plan"
annual equity award financial
"Restricted shares granted pursuant to Issuer's Amended and Restated 2008 Incentive Compensation Plan, in connection with annual equity award"
trustees financial
"The Reporting Person and her husband are trustees of the trust that holds the reported securities"
Trustees are people or a small group legally appointed to hold and manage assets, documents, or obligations on behalf of others and must act in those beneficiaries’ best interests. Think of them as a neutral guardian or custodian who enforces rules, protects assets, and makes decisions that can affect payments, corporate governance, or recovery in a default — all of which directly influence investor returns and risk.
beneficiaries financial
"Members of the Reporting Person's immediate family are beneficiaries of the trust"
Beneficiaries are the people or organizations designated to receive benefits, such as money or assets, from a financial arrangement like a trust, insurance policy, or retirement plan. They matter to investors because choosing the right beneficiaries ensures that assets are passed on according to their wishes, providing financial security or support to loved ones when needed. Think of beneficiaries as the intended recipients of a gift or inheritance.
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Weis Shirley A
(Last)(First)(Middle)
1301 CONCORD TERRACE
(Street)
SUNRISE FLORIDA 33323
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
Pediatrix Medical Group, Inc. [ MD ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/07/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock05/07/2026A(1)7,196A$018,623D
Common Stock36,028IBy The Weis Family Trust U/A dtd 04/19/2002, John N.Weis & ShirleyA. Weis Trustees(2)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Restricted shares granted pursuant to Issuer's Amended and Restated 2008 Incentive Compensation Plan, in connection with annual equity award. Shares will vest on May 7, 2027.
2. The Reporting Person and her husband are trustees of the trust that holds the reported securities. Members of the Reporting Person's immediate family are beneficiaries of the trust.
Remarks:
See Exhibit 24.1 - Power of Attorney
Mary Ann E. Moore, Attorney-in-Fact05/11/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did Shirley A. Weis report in this Pediatrix (MD) Form 4 filing?

Shirley A. Weis reported receiving an equity grant of 7,196 restricted Pediatrix common shares. The filing also updates her direct and indirect holdings, including shares held through The Weis Family Trust for the benefit of her immediate family.

How many Pediatrix (MD) shares were granted to Shirley A. Weis?

She was granted 7,196 restricted shares of Pediatrix common stock. The shares were issued at a price of $0.00 per share as part of her annual equity award under the company’s Amended and Restated 2008 Incentive Compensation Plan.

When do Shirley A. Weis’s newly granted Pediatrix (MD) restricted shares vest?

The 7,196 restricted shares granted to Shirley A. Weis are scheduled to vest on May 7, 2027. Vesting means the shares become fully hers over time, aligning her compensation with Pediatrix’s longer-term performance and director service.

What are Shirley A. Weis’s Pediatrix (MD) shareholdings after this Form 4 grant?

After the grant, Shirley A. Weis directly owns 18,623 Pediatrix common shares. She is also reported as indirectly owning 36,028 shares through The Weis Family Trust, where she and her husband are trustees and her immediate family are beneficiaries.

Was the Pediatrix (MD) transaction a market purchase or a compensation award?

The transaction was a compensation-related award of restricted shares, not a market purchase. The Form 4 shows code “A,” indicating a grant or award made at $0.00 per share as part of her annual equity compensation package.

How are the indirectly owned Pediatrix (MD) shares held for Shirley A. Weis?

The 36,028 indirectly owned Pediatrix shares are held by The Weis Family Trust. Shirley A. Weis and her husband act as trustees, and members of her immediate family are beneficiaries of this trust structure, as disclosed in the filing footnote.